Synthetic Biology

Breakthrough in Multi-Directional Collagen Tissue Engineering
Biotech & Bioprocessing Breakthrough in Multi-Directional Collagen Tissue Engineering

Recent advancements in multi-directional collagen tissue engineering are promising to redefine the future of bioengineering and regenerative medicine. Collagen, a cornerstone protein in the human body, is essential for maintaining structural integrity and mechanical strength in various tissues.

Are 3D-Printed Foods the Future of Customized Nutrition?
Biotech & Bioprocessing Are 3D-Printed Foods the Future of Customized Nutrition?

The synergy of synthetic biology and 3D printing technology has created a significant shift in food production, promising a profound impact on both industry practices and consumer experiences. By transforming the way meals are created and consumed, this blend of technology offers potential

Biotech Revolutionizing Warfare: Nations Race for Dominance
Biotech & Bioprocessing Biotech Revolutionizing Warfare: Nations Race for Dominance

Modern warfare is in the midst of a profound transformation as biotechnology reshapes military strategies globally. This evolution is driven by innovations such as gene editing, synthetic biology, and engineered organisms, transitioning from speculative ideas to tangible applications. These

India's DBT and BIRAC Launch Bio-AI Proposal Drive
Tech & Innovation India's DBT and BIRAC Launch Bio-AI Proposal Drive

In a significant stride toward revolutionizing biotechnology, India's Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) have jointly launched a call for proposals in the dynamic field of Bio-AI. This initiative is an integral part of the

Can 3D Collagen Scaffolds Transform Tissue Engineering?
Biotech & Bioprocessing Can 3D Collagen Scaffolds Transform Tissue Engineering?

In recent years, the field of tissue engineering has witnessed groundbreaking advancements, one of which is the development of 3D-printed collagen scaffolds by researchers at the University of Pittsburgh. This innovative technology, named CHIPS—collagen-based, high-resolution, internally perfusable

CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out
Research & Development CROs Shift to Alternative Methods Following FDA Animal Testing Phase-Out

Chinese contract research organization GemPharmatech has expanded its presence in the United States with a new facility in San Diego, announced on April 17. The facility is designed for laboratories and housing genetically engineered mouse models, aimed at enhancing their capabilities in offering

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later